lncRNA GK-IT1 influences the carcinogenesis of non-small cell lung cancer cells through regulating aldolase A

doi:10.3969/j.issn.1674-8115.2022.05.006

Abstract

Abstract: Objective

·To investigate the effects of long non-coding RNA (lncRNA) GK-IT1 on the carcinogenesis of non-small-cell lung cancer (NSCLC) A549 and H358 cells by regulating aldolase A (ALDOA).

Methods

·The expression of GK-IT1 in 42 pairs of NSCLC tissues and adjacent tissues, and NSCLC cell lines were tested by quantitative real-time PCR (qRT-PCR). The subcellular localization of GK-IT1 in A549 and H358 cells was tested by fluorescence in situ hybridization (FISH). RNA immunoprecipitation (RIP) was used to assess the interaction of GK-IT1 and ALDOA. A549 and H358 cells were transfected with GK-IT1 small interfering RNA sequences (Si-GK-IT1 #1 and Si-GK-IT1 #2) and negative control (Si-NC), and then the two cell lines were also cotransfected with Si-GK-IT1 #2 and ALDOA overexpression plasmid. The Si-NC, Si-GK-IT1 #1, Si-GK-IT1 #2 groups were set. CCK-8 and EdU assay were used to detect cell proliferation. Transwell invasion and scratch assay were used to observe cell invasion and migration. Western blotting was carried out to verify the expression of vimentin, E-cadherin, N-cadherin and ALDOA in each experimental group.

Results

·Compared with the normal tissues, the relative expression of GK-IT1 was significantly higher in NSCLC tissues. Compared with BEAS-2B cells, the expression of GK-IT1 in H358 and A549 cells was significantly higher (P<0.05). FISH assay indicated that GK-IT1 was mainly located in the cytoplasm. RIP and bioinformatics analysis suggested that GK-IT1 might interact with ALDOA. Compared with the Si-NC group, the results of CCK-8 assay showed that the cell proliferation of the Si-GK-IT1 #1 and Si-GK-IT1 #2 group was significantly inhibited (P<0.05). The results of EdU assay showed that the ratio of EdU positive cells in the Si-GK-IT1 #1 and Si-GK-IT1 #2 group was significantly lower than that in the Si-NC group (P<0.05). Compared with the Si-NC group, the results of Transwell invasion assay indicated that the invasion of the Si-GK-IT1 #1 and Si-GK-IT1 #2 group was significantly inhibited (all P=0.000). The results of cell scratch assay showed that the healed wound ratio in the Si-GK-IT1 #1 and Si-GK-IT1 #2 group was remarkably lower than that in Si-NC group (all P=0.000). GK-IT1 knockdown significantly decreased the expression of ALDOA and vimentin, while the expression of E-cadherin was increased. Overexpression of ALDOA reversed the effects of GK-IT1 silencing on cell proliferation, invasion, migration and protein expression of NSCLC cells (all P<0.05).

Conclusion

·GK-IT1 could promote the proliferation, invasion and migration of NSCLC cells via regulating ALDOA.

Key words: long non-coding RNA (lncRNA), GK-IT1, aldolase A (ALDOA), non-small cell lung cancer (NSCLC), cell invasion, cell migration

CLC Number:

R734.2

LIU Ziyang, WANG Xiaowen, CHEN Li. lncRNA GK-IT1 influences the carcinogenesis of non-small cell lung cancer cells through regulating aldolase A[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(5): 591-601.

Figures/Tables 9

Fig 1 Expression of GK-IT1 and ALDOA in NSCLC tissues

Fig 2 GK-IT1 expression and knockdown effect in NSCLC cell lines

Fig 3 E?ects of GK-IT1 knockdown on the proliferation of NSCLC cells

Fig 4 Effects of GK-IT1 knockdown on the invasion and migration of NSCLC cells

Fig 5 Subcellular localization of GK-IT1

Fig 6 Effects of GK-IT1 knockdown on the expression of ALDOA and EMT-related proteins in NSCLC cells

Fig 7 Interaction between GK-IT1 and ALDOA

Fig 8 Effects of ALDOA overexpression on the proliferation, invasion and migration of GK-IT1-knockdown NSCLC cells

Fig 9 Effects of ALDOA overexpression on the expression of ALDOA and EMT-related proteins in GK-IT1-knockdown NSCLC cells

TrendMD

References 27

1	CHEN Z Y, LEI T Y, CHEN X, et al. Long non-coding RNA in lung cancer[J]. Clin Chim Acta, 2020, 504: 190-200.
2	刘宗超, 李哲轩, 张阳, 等. 2020全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-14.
	LIU Z C, LI Z X, ZHANG Y, et al. Interpretation on the report of Global Cancer Statistics 2020[J]. J Multidiscip Cancer Manag (Electron Version), 2021, 7(2): 1-14.
3	LU W, ZHANG H H, NIU Y Q, et al. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p[J]. Mol Cancer, 2017, 16(1): 118.
4	CHANG Y C, YANG Y C, TIEN C P, et al. Roles of aldolase family genes in human cancers and diseases[J]. Trends Endocrinol Metab, 2018, 29(8): 549-559.
5	ZHANG F, LIN J D, ZUO X Y, et al. Elevated transcriptional levels of aldolase A (ALDOA) associates with cell cycle-related genes in patients with NSCLC and several solid tumors[J]. BioData Min, 2017, 10: 6.
6	CUI K, JIN S L, DU Y B, et al. Long noncoding RNA DIO₃OS interacts with miR-122 to promote proliferation and invasion of pancreatic cancer cells through upregulating ALDOA[J]. Cancer Cell Int, 2019, 19: 202.
7	SUN J, HE D, FU Y B, et al. A novel lncRNA ARST represses glioma progression by inhibiting ALDOA-mediated actin cytoskeleton integrity[J]. J Exp Clin Cancer Res, 2021, 40(1): 187.
8	XIAO Y H, SU M, OU W, et al. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer[J]. Biomed Pharmacother, 2019, 117: 109192.
9	SUZUKI H, MARUYAMA R, YAMAMOTO E, et al. Relationship between noncoding RNA dysregulation and epigenetic mechanisms in cancer[J]. Adv Exp Med Biol, 2016, 927: 109-135.
10	KHORKOVA O, HSIAO J, WAHLESTEDT C. Basic biology and therapeutic implications of lncRNA[J]. Adv Drug Deliv Rev, 2015, 87: 15-24.
11	DOU Q R, XU Y, ZHU Y Y, et al. lncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein[J]. Eur J Pharmacol, 2019, 852: 134-141.
12	SHEN L, HAN J, WANG H Y, et al. Cachexia-related long noncoding RNA, CAAlnc1, suppresses adipogenesis by blocking the binding of HuR to adipogenic transcription factor mRNAs[J]. Int J Cancer, 2019, 145(7): 1809-1821.
13	YANG Y X, CHEN D, LIU H, et al. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma[J]. Cell Death Dis, 2019, 10(2): 41.
14	杨鑫, 陈力. 敲低长链非编码RNA GK-IT1抑制食管鳞状癌细胞增殖和促进凋亡[J]. 第三军医大学学报, 2021, 43(2): 146-155.
	YANG X, CHEN L. Knock-down of long non-coding RNA GK-IT1 inhibits proliferation and promotes apoptosis in esophageal carcinoma cells[J]. J Army Med Univ, 2021, 43(2): 146-155.
15	PORTO F W, DAULATABAD S V, JANGA S C. Long non-coding RNA expression levels modulate cell-type-specific splicing patterns by altering their interaction landscape with RNA-binding proteins[J]. Genes, 2019, 10(8): 593.
16	CHEN J, WANG R, ZHANG K, et al. Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets[J]. J Cell Mol Med, 2014, 18(12): 2425-2436.
17	LI L, ZHANG K J, LU C H, et al. Caveolin-1-mediated STAT3 activation determines electrotaxis of human lung cancer cells[J]. Oncotarget, 2017, 8(56): 95741-95754.
18	LI J, HE M R, XU W, et al. LINC01354 interacting with hnRNP-D contributes to the proliferation and metastasis in colorectal cancer through activating Wnt/β-catenin signaling pathway[J]. J Exp Clin Cancer Res, 2019, 38(1): 161.
19	FU H L, GAO H J, QI X Y, et al. Aldolase A promotes proliferation and G₁/S transition via the EGFR/MAPK pathway in non-small cell lung cancer[J]. Cancer Commun (Lond), 2018, 38(1): 18.
21	DU S, GUAN Z Z, HAO L H, et al. Fructose-bisphosphate aldolase A is a potential metastasis-associated marker of lung squamous cell carcinoma and promotes lung cell tumorigenesis and migration[J]. PLoS One, 2014, 9(1): e85804.
22	LU Y J, LIU X, XIE M H, et al. The NF-κB-responsive long noncoding RNA FIRRE regulates posttranscriptional regulation of inflammatory gene expression through interacting with hnRNPU[J]. J Immunol, 2017, 199(10): 3571-3582.
23	TULCHINSKY E, DEMIDOV O, KRIAJEVSKA M, et al. EMT: a mechanism for escape from EGFR-targeted therapy in lung cancer[J]. Biochim Biophys Acta Rev Cancer, 2019, 1871(1): 29-39.
25	HE R, ZHANG F H, SHEN N. lncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC)[J]. Biomed Pharmacother, 2017, 95: 331-338.
26	LIU B, Sun L J, LIU Q, et al. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis[J]. Cancer Cell, 2015, 27(3):370-381.
27	YANG F, ZHANG H F, MEI Y D, et al. Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect[J]. Mol Cell, 2014, 53(1): 88-100.

[1]	ZHANG Xianzhou, DU Fenglin, WU Lei, REN Yizhe, ZHAO Mingna, LOU Jiatao. Mechanistic study of OGT-promoted non-small cell lung cancer proliferation via the ERK signaling pathway [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(10): 1288-1297.
[2]	QIAN Liheng, WEN Kailing, LIAO Yingna, LI Shuxin, NIE Huizhen. Study on the effect and mechanism of sorting nexin 1 on inhibiting the proliferation and migration of colorectal cancer cells [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(9): 1124-1135.
[3]	TAN Lu, SHEN Shaoming, HE Ping. Function and mechanism study of hypoxia-induced long non-coding RNA 68 in hepatocellular carcinoma [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(6): 702-712.
[4]	LI Huxiao, LI Xiaotian, ZHAO Xuri, ZHANG Huanyu, ZHOU Wei, SONG Zhongchen. Effects of gingipain extract on the biological characteristics of oral squamous cell carcinoma cell HN6 [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(2): 161-168.
[5]	LIU Chenxi, HAN Lin, YANG Yi, ZHOU Han, LIU Yayun, SHENG Deqiao. GPR87 promotes invasion and migration through the RHO/ROCK pathway in non-small cell lung cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(12): 1514-1525.
[6]	GAO Kexing, LIAO Chunhua, LI Shengze, MA Shuangyu, HUANG Lei. Functional site analysis of mucin 1 in regulating the malignant characteristics of tumor cells [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(11): 1370-1382.
[7]	YU Li, SU Xiandu, ZHANG Min, LI Yahui, WANG Le. Construction and validation of prognostic risk model for hepatocellular carcinoma based on biological analysis of palmitoyl-associated enzyme long-chain non-coding RNA [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(6): 747-754.
[8]	HUANG Huayan, XU-ZHANG Wendi, XIA Liliang, YU Yongfeng, LU Shun. Advances in immunotherapy of advanced non-small cell lung cancer with EGFR mutation [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(5): 611-618.
[9]	ZHAO Zhuoming, LIU Zhenhao, LU Manman, ZHANG Yu, XU Linfeng, XIE Lu. Analysis of tumor-related features of non-small cell lung cancer based on TCR repertoire workflow [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(12): 1520-1528.
[10]	LIAO Yahui, LIU Liyun, ZHU Hongrui, LIN Houwen, YAN Jizhou, SUN Fan. Marine sponge-derived smenospongine overcomes resistance of cisplatin via inhibiting EGFR-Akt-ABCG2 pathway in NSCLC cells [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(8): 997-1007.
[11]	Ming CHEN, Jing ZHANG. Inhibitory effect of sanguinarine on proliferaton and invasion of gastric cancer cells by upregulating m⁶A methyltransferase 14 [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2022, 42(2): 135-141.
[12]	YUAN Yongmei, CHENG Xiaodan, SUN Jiaan, CHANG Dongge, HE Yingying, LIU Chang. lncRNA NEAT1 affects the proliferation, invasion and migration of ox-LDL-induced human vascular smooth muscle cells through miR-377-3p/Wnt pathway [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(11): 1534-1541.
[13]	LI Ruonan, CHEN Xiaoke, XU Yuanyuan, TAN Qiang. Advances in postoperative adjuvant targeted therapy for patients with stage ⅠB-ⅢA non-small cell lung cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(11): 1612-1619.
[14]	Yun-fang MA, Li-na PAN, Zhen LI, Bei-li GAO, Jia-an HU, Zhi-hong XU. Exploratory study on downregulation of PD-L1 in KRAS G12V-mutant non-small cell lung cancer cells by selumetinib [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 741-748.
[15]	Yu-sheng LU, Wen-yi YANG, Hai-long MA, Jing-zhou HU. Impact of Ras association domain family 5 on cell migration and invasion of head and neck squamous cell carcinoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 717-723.